, or"smart drugs," are cognitive enhancers that may help boost energy, focus, and memory.)
"All the manufacturers in the United States that we found were owned by this massive gum conglomerate," explained Yoshimura."So we went on His roommate, who is now the COO of Neuro, helped him unpack the boxes. The start-up's customer service line at the time was Yoshimura's phone number. Robert Herjavec offered them $1 million for a 20% stake of the company, while Kevin O'Leary offered $750,000 for a 5% stake plus a royalty of $0.50 per unit sold until he recouped $1 million.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite: